OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
35
Results
Show all
Save search
Copy query
Show results for
Unknown
(35)
Release Date
2025
(6)
2022
(6)
2020
(4)
2024
(3)
2023
(3)
2021
(3)
2016
(3)
2018
(2)
2019
(1)
2017
(1)
2014
(1)
2012
(1)
2006
(1)
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
Reviewing deaths in British and US hospitals: a study of two scales for assessing preventability.
Not available
S-EPMC5530333
|
biostudies-literature
Cite
SCN8A encephalopathy: Research progress and prospects.
Not available
S-EPMC5495462
|
biostudies-literature
Cite
Development and Reporting of Prediction Models: Guidance for Authors From Editors of Respiratory, Sleep, and Critical Care Journals.
Not available
S-EPMC7161722
|
biostudies-literature
Cite
The Comparing Options for Management: PAtient-centered REsults for Uterine Fibroids (COMPARE-UF) registry: rationale and design.
Not available
S-EPMC8889489
|
biostudies-literature
Cite
Midcourse correction to a clinical trial when the event rate is underestimated: the Look AHEAD (Action for Health in Diabetes) Study.
Not available
S-EPMC3790961
|
biostudies-literature
Cite
Developing a quality criteria framework for patient decision aids: online international Delphi consensus process.
Not available
S-EPMC1553508
|
biostudies-literature
Cite
A New Prognostic Model in Patients with Advanced Urothelial Carcinoma Treated with First-line Immune Checkpoint Inhibitors.
Not available
S-EPMC8169524
|
biostudies-literature
Cite
Analysis of Long-term Follow-up of a Randomized Clinical Trial With Departures From Assigned Treatments: Estimation of Metformin Effects on Diabetes and Its Complications in the Diabetes Prevention Program Outcomes Study.
Not available
S-EPMC12451852
|
biostudies-literature
Cite
Cost-effectiveness of Aflibercept Monotherapy vs Bevacizumab First Followed by Aflibercept If Needed for Diabetic Macular Edema.
Not available
S-EPMC9896372
|
biostudies-literature
Cite
Association of prior local therapy and outcomes with programmed-death ligand-1 inhibitors in advanced urothelial cancer.
Not available
S-EPMC10257152
|
biostudies-literature
Cite
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets